- Home
- GROV vs LVTX Comparison
GROV vs LVTX Comparison
Compare GROV & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROV
- LVTX
- Stock Information
- Founded
- GROV 2016
- LVTX 2016
- Country
- GROV United States
- LVTX Netherlands
- Employees
- GROV N/A
- LVTX N/A
- Industry
- GROV Package Goods/Cosmetics
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- GROV Consumer Discretionary
- LVTX Health Care
- Exchange
- GROV Nasdaq
- LVTX Nasdaq
- Market Cap
- GROV 53.5M
- LVTX 33.9M
- IPO Year
- GROV N/A
- LVTX 2021
- Fundamental
- Price
- GROV $1.19
- LVTX N/A
- Analyst Decision
- GROV Hold
- LVTX Hold
- Analyst Count
- GROV 1
- LVTX 3
- Target Price
- GROV $1.20
- LVTX $1.75
- AVG Volume (30 Days)
- GROV 76.6K
- LVTX 12.3K
- Earning Date
- GROV 08-07-2025
- LVTX 08-19-2025
- Dividend Yield
- GROV N/A
- LVTX N/A
- EPS Growth
- GROV N/A
- LVTX N/A
- EPS
- GROV N/A
- LVTX N/A
- Revenue
- GROV $193,427,000.00
- LVTX $4,990,000.00
- Revenue This Year
- GROV N/A
- LVTX N/A
- Revenue Next Year
- GROV $6.22
- LVTX N/A
- P/E Ratio
- GROV N/A
- LVTX N/A
- Revenue Growth
- GROV N/A
- LVTX N/A
- 52 Week Low
- GROV $1.02
- LVTX $0.85
- 52 Week High
- GROV $1.95
- LVTX $2.39
- Technical
- Relative Strength Index (RSI)
- GROV 51.35
- LVTX 52.45
- Support Level
- GROV $1.10
- LVTX $1.27
- Resistance Level
- GROV $1.19
- LVTX $1.38
- Average True Range (ATR)
- GROV 0.07
- LVTX 0.04
- MACD
- GROV 0.01
- LVTX -0.00
- Stochastic Oscillator
- GROV 82.05
- LVTX 44.64
About GROV Grove Collaborative Holdings Inc.
Grove Collaborative Holdings Inc is engaged in providing consumer products. It offers Cleaning accessories, Home and Pantry, Personal care products, Pets supplements and Other products. It is a sustainability oriented consumer products generator. It use connection with consumers to create and curate authentic, disruptive brands and products. Company builds natural products that perform as well as, many consumer packaged goods (CPG) brands (both conventional and natural), while being healthier for consumers and the planet.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.